ATOSSA THERAPEUTICS, INC. Annual Return On Equity in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Atossa Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2023.
  • Atossa Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -29.2 %, a 6.15% decline year-over-year.
  • Atossa Therapeutics, Inc. annual Return On Equity for 2023 was -29.6 %, a 39% decline from 2022.
  • Atossa Therapeutics, Inc. annual Return On Equity for 2022 was -21.3 %, a 45.3% decline from 2021.
  • Atossa Therapeutics, Inc. annual Return On Equity for 2021 was -14.6 %, a 88.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -29.6 -8.29 -39% Jan 1, 2023 Dec 31, 2023
2022 -21.3 -6.63 -45.3% Jan 1, 2022 Dec 31, 2022
2021 -14.6 +112 +88.4% Jan 1, 2021 Dec 31, 2021
2020 -127 -20.9 -19.8% Jan 1, 2020 Dec 31, 2020
2019 -106 +13.7 +11.5% Jan 1, 2019 Dec 31, 2019
2018 -119 +115 +49.2% Jan 1, 2018 Dec 31, 2018
2017 -235 -61.5 -35.5% Jan 1, 2017 Dec 31, 2017
2016 -173 +0.74 +0.43% Jan 1, 2016 Dec 31, 2016
2015 -174 -82.9 -90.9% Jan 1, 2015 Dec 31, 2015
2014 -91.2 +24.2 +20.9% Jan 1, 2014 Dec 31, 2014
2013 -115 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.